Indefinite Delivery Contract SPE2DR25D9237

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple firm-fixed-price, requirements-type contracts for worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, United States Coast Guard, and US Naval Fleet. The estimated total value of the contract is $30.3 billion over a 30-month base period and three...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has issued a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. This is an unrestricted, multiple-award contract vehicle to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, United States Coast Guard, and US Naval Fleet. The contract will cover a comprehensive range of pharmaceutical products,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish Prime Vendor Contracts for worldwide pharmaceutical support to Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet. The contract will have a 30-month base period and three 30-month...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The purpose is to establish Prime Vendor Contracts to provide worldwide pharmaceutical support, including brand, generic, and specialty drugs, as well as related medical products, to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has issued a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The purpose is to establish multiple prime vendor contracts to provide worldwide pharmaceutical support, including brand, generic, and specialty drugs, as well as pharmaceutical-related products, to the Department of Defense (DoD), United States Coast Guard, and other designated government agencies and...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple prime vendor contracts for providing worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is establishing a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and US Naval Fleet. The contract, valued at an estimated $30.3 billion, will be awarded to multiple prime vendors on a regional basis, with at least three different...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is issuing a solicitation to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and other designated providers. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The IDC covers a 30-month base period with three 30-month option periods, totaling an estimated $30.3 billion in value across multiple regional contracts. This IDC, known as the Pharmaceutical Prime Vendor Global Program Generation...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract aims to provide worldwide pharmaceutical support, including branded, generic, and specialty pharmaceuticals, to various Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, and Other Government Agencies. The contract is a firm-fixed price,...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple Prime Vendor Contracts for worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency (DHA), Department of Defense (DoD), United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet.

The resulting contracts will be firm-fixed price requirements contracts with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contracts will cover a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) across CONUS and OCONUS locations. The solicitation will be an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation method, with the potential use of reverse auctions to determine the final distribution fees.

Generated 6/6/25, 9:44 AM